Dr. Vijaya R Dasika

M.D. | Neurology


  9245 Kennedy Blvd, North Bergen
     New Jersey, 07047-5322
  201-868-2311    201-868-9292 Maps & Directions
Dr. Vijaya R Dasika is a North Bergen, New Jersey based neurologist who is specialized in Neurology. His current practice location is 9245 Kennedy Blvd, North Bergen. Patients can reach him at 201-868-2311 or can fax him at 201-868-9292. Dr. Vijaya R Dasika is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1780625541.
Dr. Vijaya R Dasika specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Vijaya R Dasika speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Vijaya R Dasika
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:9245 Kennedy Blvd, North Bergen,
New Jersey, 07047-5322
Phone:201-868-2311
Fax:201-868-9292
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1780625541
NPI Enumeration Date: 10 Jun, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Vijaya R Dasika
9245 Kennedy Blvd,
North Bergen, New Jersey
Zip: 07047-5322
Phone Number: 201-868-2311
Fax Number: 201-868-9292
Patients can reach Dr. Vijaya R Dasika at 9245 Kennedy Blvd, North Bergen, New Jersey or can call to book an appointment on 201-868-2311.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.